Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Glenmark Pledges 50 Lakh Meals for Undernourished Children, Pregnant Women and Daily Wage Earners Amidst COVID-19 Pandemic

Glenmark Logo

News provided by

Glenmark Pharmaceuticals Ltd.

22 Apr, 2020, 18:09 IST

Share this article

Share toX

Share this article

Share toX

  • Additionally over 3,00,000 beneficiaries to be reached across Himachal Pradesh, Madhya Pradesh and Gujarat via tele-medicine by medical specialists
  • More than 10,000 pregnant women and lactating mothers to be supported via tele-counselling and on-ground healthcare activities
  • Sanitizers to be donated across villages, housing societies, police stations and Government offices in Madhya Pradesh, Goa, Maharashtra, Sikkim, Gujarat and Himachal Pradesh

MUMBAI, April 22, 2020 /PRNewswire/ -- As millions across the country grapple with the COVID-19 pandemic, Glenmark Foundation, the CSR arm of Glenmark Pharmaceuticals along with its NGO partners, is working closely in alignment with government directives and state health authorities to extend its support - through a combination of on-ground and remote health initiatives.

Glenmark's community outreach efforts are in line with the Prime Minister's call to action to support the society's most vulnerable and disadvantaged people. Glenmark Foundation has pledged support in the form of food aid and health services for undernourished children, pregnant and lactating women, migrants, daily wage earners and healthcare providers on the frontlines of the outbreak.

A key intervention is the launch of a tele-health solution by the Foundation and its NGO partner Institute for Global Development (IGD), which follows guidelines framed by the governors of the Medical Council of India (MCI) and NITI Aayog. A battery of medical doctors with various specialisations have committed support for the on-call service and have been mobilised to expand access to quality patient care. The services are being rolled out for over 3,00,000 people across the states of Himachal Pradesh, Gujarat and Madhya Pradesh.

Commenting on Glenmark's efforts, Ms. Cherylann Pinto, Executive Director, Corporate Services of Glenmark Pharmaceuticals said, "Giving back to the community has always been a Glenmark priority. The COVID-19 pandemic makes it even more imperative for us to support the country's most vulnerable populations. We are working with the government and our NGO partners across states to extend our support on multiple fronts, to address the needs and challenges during this outbreak."

Glenmark's efforts across Maharashtra, Gujarat, Himachal Pradesh, Madhya Pradesh, Goa and Sikkim are intended to support the local authorities and work in synergy with the states in the nation's fight against COVID-19. Amidst the present crisis which has brought on a nationwide lockdown, Glenmark is providing psychological support to 10,000 lactating mothers and pregnant women through tele-counselling. Additionally it is also undertaking vaccination, attending to women undergoing antennal care (ANC), and postnatal care (PNC), and providing health support to children and other patients.

The Foundation is also extending support by ensuring adequate monthly supply of food grains to undernourished children, pregnant and lactating women in 70 tribal villages, in Khandwa, Madhya Pradesh and 10 tribal hamlets in Sanjay Gandhi National Park, Mumbai. Apart from these, it has undertaken several initiatives - partnering with local administrations to extend support and feed families of migrant and daily wage workers during the lockdown. Glenmark Foundation is also providing Personal Protective Equipment (PPE) to medical staff in the public health sector in Maharashtra. PPE includes medical masks and gowns, gloves, eye and head protection gear, sanitizers, etc., all of which are critical for health workers. Over 3,500 litres of sanitizers are being distributed across villages, housing societies, police stations and government offices across these states.

In acknowledgement of the contribution of law enforcement agencies during this unprecedented time, Glenmark has conducted medical check-ups for 400+ local law enforcement personnel in Ankleshwar, Gujarat.

Glenmark Pharmaceuticals has also donated over INR 1.5 crores to various states' CM Funds and to the PM CARES Fund. In addition, Glenmark will be supplementing to the funds donated generously by its employees for the COVID-19 relief activities.

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. (GPL) is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. Glenmark's key therapy focus areas globally are respiratory, dermatology and oncology. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenue (SCRIP 100 Rankings published in the year 2019).

For more information, visit www.glenmarkpharma.com

About Glenmark Foundation

Themed around 'Healthier Children, Healthier World', Glenmark Foundation, the CSR arm of Glenmark Pharmaceuticals, is actively working towards improving maternal and child health. Glenmark Foundation aims to encourage a positive health seeking behaviour among pregnant women and mothers with infants, and caregivers towards right nutrition including - good hygiene practices and ensuring complete immunization for children. Along with its NGO partners, the foundation has undertaken several community programs focused towards reducing infant and child mortality among the vulnerable population groups. The various interventions in child health are spread across Madhya Pradesh, Maharashtra, Himachal Pradesh, Sikkim and Gujarat in India. The Foundation has also taken up the cause of creating a Sustainable livelihood for the marginalized and improving access to healthcare through its other programmes.

Media Contact:
Madhurima Gupta Jain
[email protected]
+91-22-4018-9606
Sr. Manager, Glenmark Pharmaceuticals Ltd.

Logo: https://mma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.